Who owns Regenity Biosciences?

Regenity Biosciences is currently owned by Cinven, through Cinven Fund VIII, since 2026.

When did Cinven acquire Regenity Biosciences?

Cinven acquired Regenity Biosciences in 2026 (active for 0 years).

Home/Companies/Healthcare/Regenity Biosciences

Regenity Biosciences

Healthcare·

US·Active·0yr hold

Regenity Biosciences is a healthcare company, headquartered in United States.

Entry

2026

Hold

0yr

Status

Active

Est. EV

–

Investor

Cinven

Key facts

HQUnited States

SectorHealthcare

Bioresorbable technologies for tissue and bone regeneration. 250+ employees, 80+ FDA-approved products. Cinven strategic investment…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Cinven Fund VIII

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings